News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Buten Matthew
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/06/2023 |
4
| Buten Matthew (CFO) has filed a Form 4 on Biohaven Ltd.|
Txns:
| Bought 22,727 shares
@ $22, valued at
$500k
|
|
| 10/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Buten Matthew (CFO) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Disposed/sold 6,177 shares
@ $148.5, valued at
$917.3k
Disposed/sold 37,500 options to buy
@ $0
Disposed/sold 3,100 options to buy
@ $0
Disposed/sold 22,900 options to buy
@ $0 |
|
| 09/28/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/07/2022 |
4
| Buten Matthew (CFO) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Granted 26,000 options to buy
@ $128.87, valued at
$3.4M
|
|
| 01/04/2022 |
4
| Buten Matthew (CFO) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Paid exercise price by delivering 6,323 shares
@ $137.81, valued at
$871.4k
Exercised 12,500 options to buy
@ $0 |
|
| 12/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|